Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Tofacitinib helped a woman regrow hair with no major side effects.

A hair-growth formula with cystine and thiamin helps protect skin cells against UV damage and improves their growth.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib may help treat severe hair loss, but more research is needed.

Topical IKKα inhibitors may help prevent CCS tumours.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Adding a second method to PROTACs could improve cancer treatment.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Nilotinib can cause generalized keratosis pilaris.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Some drugs used to treat immune conditions may cause different types of hair loss.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.